Correlation Between Recursion Pharmaceuticals and Koss

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Koss at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Koss into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Koss Corporation, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Koss and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Koss. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Koss.

Diversification Opportunities for Recursion Pharmaceuticals and Koss

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Recursion and Koss is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Koss Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Koss and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Koss. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Koss has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Koss go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and Koss

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to under-perform the Koss. But the stock apears to be less risky and, when comparing its historical volatility, Recursion Pharmaceuticals is 1.79 times less risky than Koss. The stock trades about -0.01 of its potential returns per unit of risk. The Koss Corporation is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  367.00  in Koss Corporation on September 12, 2024 and sell it today you would earn a total of  355.00  from holding Koss Corporation or generate 96.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  Koss Corp.

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Koss 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days Koss Corporation has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Koss is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Recursion Pharmaceuticals and Koss Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and Koss

The main advantage of trading using opposite Recursion Pharmaceuticals and Koss positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Koss can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Koss will offset losses from the drop in Koss' long position.
The idea behind Recursion Pharmaceuticals and Koss Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device